標題: Cu) Risks, results, and benefits [打印本頁] 作者: IPTMellisa 時間: 前天 00:53 標題: Cu) Risks, results, and benefits Its impacts, nevertheless, are still being studied through various research, which is why ghk cu peptide dose-Cu has not been approved by the FDA as of yet.